RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Zabota 2.0

Company

Content

Owners

+ Selivanov Dmitry Vadimovich

Zabota 2.0 is a Russian medical startup that develops a system for automating patient care, prevention and medical marketing. The company helps private clinics automate marketing and communication with patients using an array of medical data: medical histories, diagnoses made, predictions of doctors, etc. This method of individual care significantly increases the loyalty of people and motivates them to monitor their health more carefully by re-visiting clinics, the developers say.

Zabota 2.0 was founded in 2014 by Dmitry Laptev and Vladimir Selivanov.

History

2021: Attracting investments from Sergey Solonin

On April 20, 2021, it became known about the investments of QiwiGroup co-founder Sergei Solonin in Zabota 2.0. The financial terms of the transaction are not disclosed.

According to the Unified State Register of Legal Entities, the founders startup Dmitry Laptev Vladimir Selivanov each own 36.25% in LLC "" Medicine(legal entity Zabota 2.0). Alena Kalimullina owns 14.5%, Ruslan Kalimullin - 9.67%. Sergey Solonin received 3.33% in a startup.

By April 2021, about 700 clinics were connected to the Zabota 2.0 platform, in 2021 the company plans to increase their number to 3 thousand.

Sergey Solonin invested in medtech startup Zabota 2.0
File:Aquote1.png
A distinctive feature of millennials is that they trust ratings and real reviews more, absolutely do not believe in brands and are fully involved in digital technologies, "said Zabota 2.0 co-founder Dmitry Laptev, commenting on the news of Sergey Solonin's investments.
File:Aquote2.png

According to Solonin, the future of private clinics depends on the effective use of information technologies in the processing of medical data that take into account the characteristics of the generation of millennials. Zabota 2.0 predicts that from 2023, more than 50% of the income of private clinics will depend on the generation of people born between 1980 and 2000.[1]

Notes